Page 55 - Practice Guidelines News Today

Share this article Share this article LONDON, April 22, 2021 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved JEMPERLI (dostarlimab-gxly), a programmed death receptor-1 (PD-1) blocking antibody, based on the companys Biologics License Application. JEMPERLI is indicated for the treatment of adult patients with mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer, as determined by an FDA-approved t...

NCCN Foundation Announces Awards for Rising Cancer Research Leaders National Comprehensive Cancer Networks Oncology Research Program to oversee projects from early-career investigators advancing key areas for study in cancer care, such as cancer prevention, racial disparities in screening, immunotherapy, new insights in radiotherapy, and CAR T-cell therapy. News provided by Share this article ® today announced six new recipients for the 2021 NCCN Foundation  Young Investigator Awards (YIA) Pr...

NCCN Announces Projects to Study Oral Decitabine and Cedazuridine in Collaboration with Taiho Oncology NCCN Oncology Research Program to oversee projects exploring oral medication combination targeting tumor suppression genes. News provided by Share this article ®) Oncology Research Program (ORP) today announced that three projects have been selected to study oral decitabine (35 mg) and cedazuridine (100 mg). The NCCN ORP convened a Scientific Review Committee to review, evaluate, and select a...

Share this article PLYMOUTH MEETING, Pa., April 13, 2021 /PRNewswire/ -- The April 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network publishes new research from Memorial Sloan Kettering Cancer Center (MSK) and Gustave Roussy Institute, which suggests that baseline brain imaging should be considered in most patients with metastatic kidney cancer. The researchers studied 1,689 patients with metastatic renal cell carcinoma (mRCC) who had been considered for clinical tria...

endIndex: Metro Manila (CNN Philippines, April 6) — Government officials advised advocates of antiparasitic drug Ivermectin to wait for the Food and Drug Administrations approval for its compassionate use before urging the public to use it as an alternative treatment to COVID-19. In his briefing on Tuesday, Presidential Spokesperson Harry Roque said the initiative of Anakalusugan Party-list Rep. Mike Defensor to distribute Ivermectin supply to the sick and elderly residents of Quezon City mi...

 E-Mail Bethesda, MD (April 6, 2021) -- Obesity is a global pandemic, affecting about 40% of adults in the United States. There is an enormous unmet need for an effective weight-loss solution. After a detailed review of available literature, the American Gastroenterological Association (AGA) has released new clinical guidelines recommending the use of intragastric balloons (IGB) for patients with obesity who have not been able to lose weight with traditional weight-loss strategies. This treatm...

Medication that could help victims of opioid use wrapped up in politics and last updated 2021-03-12 16:07:23-05 Advocates say theres a huge need for expanded access to medication as the number of victims affected by opioid use disorder continues to rise. Looking at pictures of Adam Black in a bodybuilding competition, youd never know that hes 7 years in recovery from opioid addiction. “I hit a spiritual bottom and everything around me was falling apart. I couldn’t keep anything toget...

®)—an alliance of leading cancer centers—has published new best practice recommendations for Management of COVID-19 Infection in Patients with Cancer. This new expert guidance cites more than 150 studies covering how best to manage and treat diagnosed or suspected COVID-19 in cancer patients to achieve the best possible outcomes for all conditions. The recommendations include topics such as: Who should be tested for SARS-CoV-2; Which SARS-CoV-2 tests to use; How to use/interpret PCR cycl...

Tasadenoturev (DNX-2401) by VBI Vaccines, Aivita Biomedical, Immunomic Therapeutics, and DNAtrix, respectively. Discoveries of isocitrate dehydrogenase (IDH) mutation, co-deletion of the short arm of chromosome 1 and the long arm of chromosome 19 (1p19q), O6-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation, and histone H3-K27M mutation have led to a better understanding of the molecular aberrations associated with Brain Tumors. Pondering over changing dynamics of the Brain ...

Share this article PLYMOUTH MEETING, Pa., March 9, 2021 /PRNewswire/ -- New research in the March 2021 issue of and survival in patients with advanced cancer undergoing an unplanned hospitalization. The researchers also found nearly two-thirds of the patients in that population had significant muscle loss (sarcopenia), and that those with a higher body mass index (BMI) tended to have lower muscle quality despite higher quantity. They highlight the need for additional work to continue investiga...